Debraj Bose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Debraj Bose has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Eric B. Fauman
Internal Medicine Research Unit, Pfizer Worldwide Research, Development and Medical, Cambridge, USA
3 shared publications - Heather M. Stringham
Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA
3 shared publications - Jean Morrison
Department of Biostatistics, University of Michigan, Ann Arbor, USA
3 shared publications - Laura J. Scott
Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, USA
3 shared publications - Lilian Fernandes Silva
Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland
3 shared publications - Markku Laakso
Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland
3 shared publications
Latest Publications
- Open Access
- 18 March 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (7) , 1869-1881
Plasma metabolite association profiles for type 2 diabetes genetic clusters in Finnish men
Aims/hypothesis: A recent study has suggested eight clusters of genetic variants associated with type 2 diabetes. We aimed to characterise metabolite associations for these eight clusters. Methods: We constructed type 2 diabetes overall and cluster-partitioned polygenic risk scores (PRSs) in 10,015 Finnish men with 979 named plasma metabolites measured in Metabolon HD4 mass spectrometry platform. We evaluated metabolite–PRS associations using linear regression. We also performed a mediation analysis to examine whether metabolites statistically accounted for part of the association between genetic risk and incident type 2 diabetes that developed in a mean of 13.6 years’ follow-up. Results: We identified 337 metabolites significantly associated with type 2 diabetes genetic risk, including 242 exclusive to cluster-partitioned PRSs. Of the significant metabolites, 26 exhibited significantly heterogeneous associations across clusters. We identified significant enrichment for 33 metabolic pathways among the cluster-associated metabolites. Notably, metabolites for the two pancreatic beta cell-related clusters exhibited enrichment in distinct pathways: the beta cell + proinsulin (PI) cluster in fructose, mannose and galactose metabolism; and the beta cell − PI cluster in branched-chain amino acid metabolism. Mediation analysis suggested that >50% of the associated metabolites showed patterns statistically consistent with a mediating role in the associations between PRSs and incident type 2 diabetes. Conclusions/interpretation: This study underscores the value of type 2 diabetes clustering and highlights metabolic heterogeneity across clusters. The findings have the potential to guide personalised interventions. Data availability: The datasets generated during and/or analysed in the current study are available in dbGaP (accession ID: phs000743.v4.p1 and phs004033.v1.p1).
- 18 March 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (7) , 1869-1881
Open AccessPlasma metabolite association profiles for type 2 diabetes genetic clusters in Finnish men
Aims/hypothesis: A recent study has suggested eight clusters of genetic variants associated with type 2 diabetes. We aimed to characterise metabolite associations for these eight clusters. Methods: We constructed type 2 diabetes overall and cluster-partitioned polygenic risk scores (PRSs) in 10,015 Finnish men with 979 named plasma metabolites measured in Metabolon HD4 mass spectrometry platform. We evaluated metabolite–PRS associations using linear regression. We also performed a mediation analysis to examine whether metabolites statistically accounted for part of the association between genetic risk and incident type 2 diabetes that developed in a mean of 13.6 years’ follow-up. Results: We identified 337 metabolites significantly associated with type 2 diabetes genetic risk, including 242 exclusive to cluster-partitioned PRSs. Of the significant metabolites, 26 exhibited significantly heterogeneous associations across clusters. We identified significant enrichment for 33 metabolic pathways among the cluster-associated metabolites. Notably, metabolites for the two pancreatic beta cell-related clusters exhibited enrichment in distinct pathways: the beta cell + proinsulin (PI) cluster in fructose, mannose and galactose metabolism; and the beta cell − PI cluster in branched-chain amino acid metabolism. Mediation analysis suggested that >50% of the associated metabolites showed patterns statistically consistent with a mediating role in the associations between PRSs and incident type 2 diabetes. Conclusions/interpretation: This study underscores the value of type 2 diabetes clustering and highlights metabolic heterogeneity across clusters. The findings have the potential to guide personalised interventions. Data availability: The datasets generated during and/or analysed in the current study are available in dbGaP (accession ID: phs000743.v4.p1 and phs004033.v1.p1).
- 29 July 2025
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 112 (8) , 1948-1961
Rare-variant association studies: When are aggregation tests more powerful than single-variant tests?
- 29 July 2025
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 112 (8) , 1948-1961
Rare-variant association studies: When are aggregation tests more powerful than single-variant tests?
- Open Access
- 28 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-10
Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints
Metabolites are small molecules that are useful for estimating disease risk and elucidating disease biology. Here, we perform two-sample Mendelian randomization to systematically infer the potential causal effects of 1099 plasma metabolites measured in 6136 Finnish men from the METSIM study on risk of 2099 binary disease endpoints measured in 309,154 Finnish individuals from FinnGen. We find evidence for 282 putative causal effects of 70 metabolites on 183 disease endpoints. We also identify 25 metabolites with potential causal effects across multiple disease domains, including ascorbic acid 2-sulfate affecting 26 disease endpoints in 12 disease domains. Our study suggests that N-acetyl-2-aminooctanoate and glycocholenate sulfate affect risk of atrial fibrillation through two distinct metabolic pathways and that N-methylpipecolate may mediate the putative causal effect of N6,N6-dimethyllysine on anxious personality disorder.
- 28 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-10
Open AccessAssessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints
Metabolites are small molecules that are useful for estimating disease risk and elucidating disease biology. Here, we perform two-sample Mendelian randomization to systematically infer the potential causal effects of 1099 plasma metabolites measured in 6136 Finnish men from the METSIM study on risk of 2099 binary disease endpoints measured in 309,154 Finnish individuals from FinnGen. We find evidence for 282 putative causal effects of 70 metabolites on 183 disease endpoints. We also identify 25 metabolites with potential causal effects across multiple disease domains, including ascorbic acid 2-sulfate affecting 26 disease endpoints in 12 disease domains. Our study suggests that N-acetyl-2-aminooctanoate and glycocholenate sulfate affect risk of atrial fibrillation through two distinct metabolic pathways and that N-methylpipecolate may mediate the putative causal effect of N6,N6-dimethyllysine on anxious personality disorder.
- Open Access
Nonequilibrium dynamics of suppression, revival, and loss of charge order in a laser pumped electron-phonon system
An electron-phonon system at commensurate filling often displays charge order (CO) in the ground state. Such a system subject to a laser pulse shows a wide variety of behaviour. A weak pulse sets up low amplitude oscillations in the order parameter, with slow decay to a slightly suppressed value. A strong pulse leads to the destruction of the charge order with the order parameter showing rapid, oscillatory, decay to zero. The regime in between, separating the weak pulse CO sustained state from the strong pulse CO destroyed state, shows complex dynamics characterised by multiple, pulse strength dependent, time scales. It involves an initial rapid decay of the order parameter, followed by a low amplitude quiescent state, and the power-law rise to a steady-state over a timescale $\tau_{cr}$. We provide a complete characterisation of the dynamics in this nonequilibrium problem for varying electron-phonon coupling and pulse strength, examine the possibility of an effective "thermal" description of the long time state, and present results on the multiple insulator-metal transitions that show up.Open AccessNonequilibrium dynamics of suppression, revival, and loss of charge order in a laser pumped electron-phonon system
An electron-phonon system at commensurate filling often displays charge order (CO) in the ground state. Such a system subject to a laser pulse shows a wide variety of behaviour. A weak pulse sets up low amplitude oscillations in the order parameter, with slow decay to a slightly suppressed value. A strong pulse leads to the destruction of the charge order with the order parameter showing rapid, oscillatory, decay to zero. The regime in between, separating the weak pulse CO sustained state from the strong pulse CO destroyed state, shows complex dynamics characterised by multiple, pulse strength dependent, time scales. It involves an initial rapid decay of the order parameter, followed by a low amplitude quiescent state, and the power-law rise to a steady-state over a timescale $\tau_{cr}$. We provide a complete characterisation of the dynamics in this nonequilibrium problem for varying electron-phonon coupling and pulse strength, examine the possibility of an effective "thermal" description of the long time state, and present results on the multiple insulator-metal transitions that show up. - Top Cited PapersOpen Access
- 28 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-14
Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci
Few studies have explored the impact of rare variants (minor allele frequency < 1%) on highly heritable plasma metabolites identified in metabolomic screens. The Finnish population provides an ideal opportunity for such explorations, given the multiple bottlenecks and expansions that have shaped its history, and the enrichment for many otherwise rare alleles that has resulted. Here, we report genetic associations for 1391 plasma metabolites in 6136 men from the late-settlement region of Finland. We identify 303 novel association signals, more than one third at variants rare or enriched in Finns. Many of these signals identify genes not previously implicated in metabolite genome-wide association studies and suggest mechanisms for diseases and disease-related traits.
- 28 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-14
Top Cited PapersOpen AccessGenome-wide association studies of metabolites in Finnish men identify disease-relevant loci
Few studies have explored the impact of rare variants (minor allele frequency < 1%) on highly heritable plasma metabolites identified in metabolomic screens. The Finnish population provides an ideal opportunity for such explorations, given the multiple bottlenecks and expansions that have shaped its history, and the enrichment for many otherwise rare alleles that has resulted. Here, we report genetic associations for 1391 plasma metabolites in 6136 men from the late-settlement region of Finland. We identify 303 novel association signals, more than one third at variants rare or enriched in Finns. Many of these signals identify genes not previously implicated in metabolite genome-wide association studies and suggest mechanisms for diseases and disease-related traits.